- Home
- LPCN vs WVVI Comparison
LPCN vs WVVI Comparison
Compare LPCN & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- WVVI
- Stock Information
- Founded
- LPCN 1997
- WVVI 1983
- Country
- LPCN United States
- WVVI United States
- Employees
- LPCN N/A
- WVVI N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- LPCN Health Care
- WVVI Consumer Staples
- Exchange
- LPCN Nasdaq
- WVVI Nasdaq
- Market Cap
- LPCN 13.8M
- WVVI 13.0M
- IPO Year
- LPCN N/A
- WVVI N/A
- Fundamental
- Price
- LPCN $3.18
- WVVI $2.58
- Analyst Decision
- LPCN Strong Buy
- WVVI
- Analyst Count
- LPCN 1
- WVVI 0
- Target Price
- LPCN $7.00
- WVVI N/A
- AVG Volume (30 Days)
- LPCN 54.7K
- WVVI 17.3K
- Earning Date
- LPCN 11-06-2025
- WVVI 11-13-2025
- Dividend Yield
- LPCN N/A
- WVVI N/A
- EPS Growth
- LPCN N/A
- WVVI N/A
- EPS
- LPCN N/A
- WVVI N/A
- Revenue
- LPCN $4,322,693.00
- WVVI $37,366,837.00
- Revenue This Year
- LPCN N/A
- WVVI N/A
- Revenue Next Year
- LPCN N/A
- WVVI N/A
- P/E Ratio
- LPCN N/A
- WVVI N/A
- Revenue Growth
- LPCN N/A
- WVVI N/A
- 52 Week Low
- LPCN $2.52
- WVVI $2.49
- 52 Week High
- LPCN $5.50
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- LPCN 61.21
- WVVI 32.44
- Support Level
- LPCN $3.07
- WVVI $2.50
- Resistance Level
- LPCN $3.32
- WVVI $2.78
- Average True Range (ATR)
- LPCN 0.20
- WVVI 0.20
- MACD
- LPCN 0.06
- WVVI 0.01
- Stochastic Oscillator
- LPCN 65.82
- WVVI 15.80
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.